Skip to content

Comparison of diagnostic sensitivity of peroral cholangioscopy-guided target biopsy with that of transpapillary forceps biopsy under fluoroscopic guidance in patients suspected with bile duct cancer: A multicenter retrospective cohort study

Comparison of diagnostic sensitivity of peroral cholangioscopy-guided target biopsy with that of transpapillary forceps biopsy under fluoroscopic guidance in patients suspected with bile duct cancer: A multicenter retrospective cohort study - POCS- vs ERCP-guided biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040844
Enrollment
50
Registered
2020-07-01
Start date
2020-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bile duct cancer

Interventions

None listed

Sponsors

Third Department of Internal Medicine, University of Toyama
Lead Sponsor
First Department of Internal Medicine, Gifu University Hospital and Department of Gastroenterology, Teikyo University Mizonokuchi Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients suspected with bile duct cancer who underwent biopsy under both fluoroscopy and cholangioscopy guidance in same session at University of Toyama,Gifu University, and Teikyo University Mizonokuchi Hospital between November 2013 and February 2020.

Exclusion criteria

Exclusion criteria: 1. Patients with pancreatic head mass and with dialation of upstream main pancreatic duct 2. Patients with exposure of tumor at duodenal papilla

Design outcomes

Primary

MeasureTime frame
Diagnostic sensitivity

Secondary

MeasureTime frame
accuracy, specificity, positive predictive value (PPV), negative predictive value (NPV), sample size, and sample quality

Countries

Japan

Contacts

Public ContactIchiro Yasuda

University of Toyama Third Department of Internal Medicine

yasudaic@med.u-toyama.ac.jp076-434-7300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026